COMMUNIQUÉS West-GlobeNewswire

Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026
06/10/2026
Preclinical data showed that balanced PPARα, PPARδ and PPARγ activation by lanifibranor affects complementary pathways across multiple hepatic cell populations involved in fibrosis in MASH pathogenesis Preclinical data [...]
Inventiva présentera plusieurs abstracts scientifiques lors de l’AASLD The Liver Meeting® 2026
06/10/2026
Des données précliniques montrent que l’activation équilibrée des trois isoformes PPARα, PPARδ et PPARγ par le lanifibranor agit sur des voies complémentaires au sein de plusieurs populations cellulaires hépatiques [...]
Harvard Bioscience Announces Creation of Scientific Advisory Board
06/10/2026
HOLLISTON, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the creation of its Scientific Advisory Board (SAB) to guide the Company’s ongoing research, development, and [...]
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
06/10/2026
New preclinical data further characterizes EQ504’s coordinated effects across epithelial and immune compartments in intestinal inflammation LA JOLLA, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Equillium , Inc. (Nasdaq: [...]
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
06/10/2026
Oral presentation will highlight previously reported Phase 2 HORIZON data for MZE829 in patients with APOL1-mediated kidney disease Two poster presentations will highlight preclinical research supporting the therapeutic [...]
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
06/10/2026
SEATTLE and VANCOUVER, British Columbia, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global [...]
BridgeBio to Present Additional Evidence from the Phase 3 CALIBRATE Trial of Encaleret in ADH1 at the ASBMR 2026 Annual Meeting
06/10/2026
PALO ALTO, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for [...]
BridgeBio to Present New Acoramidis Data, Including Independent Comparative Real-World EHR Data at the HFSA Annual Scientific Meeting 2026
06/10/2026
PALO ALTO, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for [...]
Acquisition of Own Shares
06/10/2026
Mechelen, Belgium; October 06, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/10/2026
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer [...]
Ozari Health Launches Ozari One: Compounded Tirzepatide Online for $125 a Month, Same Price at Every Dose
06/10/2026
The LegitScript-certified telehealth platform's new plan bills $375 every three months for compounded tirzepatide with B12, filled by one of three named US-licensed 503A compounding pharmacies, with the provider visit [...]
Community HealthCare Resources Launches Fall 2026 Clinician Recruitment Initiative
06/10/2026
Nationwide initiative invites healthcare professionals to expand access to care and explore Public Service Loan Forgiveness (PSLF) opportunities through CHR’s nonprofit model BETTENDORF, Iowa, Oct. 06, 2026 (GLOBE [...]
Remix Therapeutics™ Appoints Michael Landsittel to Board of Directors
06/10/2026
WATERTOWN, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying [...]
Recognizing Warnings Before a Crisis
06/10/2026
San Diego-based Park Mental Health Treatment Center educates community on subtle signs that shouldn’t be ignored San Diego, CA., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Every day, millions of people are fighting a battle to [...]
MedSpa Board and QUAD A Provide Joint Guidance on IV Infusion Safety Following Recent Safety Concerns
06/10/2026
HIGHLAND PARK, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Following recent FDA and CDC safety communications involving compounded injectable glutathione and related adverse events, QUAD A and MedSpa Board are providing [...]
Fast Company Names Veyond Metaverse a 2026 Next Big Things in Tech Winner for OceanMD, XR Telemedicine for Ships and Remote Sites
06/10/2026
OceanMD brings a remote physician virtually beside the medic on ships and offshore sites where specialist help can be days away SAN FRANCISCO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Veyond Metaverse , a developer of [...]
Going Beyond Addiction
06/10/2026
San Diego-based Shoreline Recovery Center highlights the importance of long-term support for individuals following addiction treatment San Diego, CA., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Achieving sobriety after addiction [...]
Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion
06/10/2026
Segment features Kevin Lundquist discussing his decision to join Outlook Therapeutics and the Company’s path forward following the FDA approval of LYTENAVA™ Access the segment here ISELIN, N.J., Oct. 06, 2026 (GLOBE [...]
Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026
06/10/2026
COPENHAGEN, Denmark, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest advances in its hypoparathyroidism and achondroplasia programs will be showcased during ASBMR [...]

Pages